JP2010533736A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010533736A5 JP2010533736A5 JP2010517200A JP2010517200A JP2010533736A5 JP 2010533736 A5 JP2010533736 A5 JP 2010533736A5 JP 2010517200 A JP2010517200 A JP 2010517200A JP 2010517200 A JP2010517200 A JP 2010517200A JP 2010533736 A5 JP2010533736 A5 JP 2010533736A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- amino
- mono
- cycloalkyl
- aminosulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC(*)(C1(CC(C2)C3)CC3CC2C1)NC(C)=O Chemical compound CC(*)(C1(CC(C2)C3)CC3CC2C1)NC(C)=O 0.000 description 17
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95062507P | 2007-07-19 | 2007-07-19 | |
| PCT/US2008/070613 WO2009012482A2 (en) | 2007-07-19 | 2008-07-21 | 5-membered heterocyclic amides and related compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013243253A Division JP5813734B2 (ja) | 2007-07-19 | 2013-11-25 | ５員複素環アミドおよび関連化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010533736A JP2010533736A (ja) | 2010-10-28 |
| JP2010533736A5 true JP2010533736A5 (enExample) | 2011-09-08 |
Family
ID=40260407
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010517200A Pending JP2010533736A (ja) | 2007-07-19 | 2008-07-21 | ５員複素環アミドおよび関連化合物 |
| JP2013243253A Expired - Fee Related JP5813734B2 (ja) | 2007-07-19 | 2013-11-25 | ５員複素環アミドおよび関連化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013243253A Expired - Fee Related JP5813734B2 (ja) | 2007-07-19 | 2013-11-25 | ５員複素環アミドおよび関連化合物 |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US20100292236A1 (enExample) |
| EP (1) | EP2178865B1 (enExample) |
| JP (2) | JP2010533736A (enExample) |
| KR (2) | KR20150118197A (enExample) |
| CN (2) | CN104844578B (enExample) |
| AU (1) | AU2008275891B2 (enExample) |
| BR (1) | BRPI0813426A2 (enExample) |
| CA (1) | CA2691507C (enExample) |
| CO (1) | CO6251318A2 (enExample) |
| CY (1) | CY1116809T1 (enExample) |
| DK (1) | DK2178865T3 (enExample) |
| EA (1) | EA017250B1 (enExample) |
| ES (1) | ES2551095T3 (enExample) |
| HK (1) | HK1213879A1 (enExample) |
| HR (1) | HRP20151052T1 (enExample) |
| HU (1) | HUE026446T2 (enExample) |
| IL (1) | IL202499A (enExample) |
| MX (1) | MX2009014159A (enExample) |
| MY (1) | MY154668A (enExample) |
| NZ (1) | NZ582057A (enExample) |
| PH (1) | PH12014501677B1 (enExample) |
| PL (1) | PL2178865T3 (enExample) |
| PT (1) | PT2178865E (enExample) |
| RS (1) | RS54303B1 (enExample) |
| SG (1) | SG187396A1 (enExample) |
| SI (1) | SI2178865T1 (enExample) |
| UA (1) | UA105758C2 (enExample) |
| WO (1) | WO2009012482A2 (enExample) |
| ZA (1) | ZA200908447B (enExample) |
Families Citing this family (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR044519A1 (es) | 2003-05-02 | 2005-09-14 | Novartis Ag | Derivados de piridin-tiazol amina y de pirimidin-tiazol amina |
| US8563573B2 (en) | 2007-11-02 | 2013-10-22 | Vertex Pharmaceuticals Incorporated | Azaindole derivatives as CFTR modulators |
| EA201000947A1 (ru) | 2007-12-20 | 2011-02-28 | Новартис Аг | Производные тиазола, применимые в качестве ингибиторов киназы pi3 |
| MX2010013705A (es) * | 2008-06-13 | 2011-02-25 | Bayer Cropscience Ag | Nuevas amidas y tioamidas heteroaromaticas como plaguicidas. |
| UA104147C2 (uk) | 2008-09-10 | 2014-01-10 | Новартис Аг | Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань |
| AU2009313198B2 (en) | 2008-11-10 | 2016-03-24 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| CN102300862B (zh) | 2008-12-19 | 2016-11-23 | 沃泰克斯药物股份有限公司 | 用作atr激酶抑制剂的化合物 |
| US8293753B2 (en) | 2009-07-02 | 2012-10-23 | Novartis Ag | Substituted 2-carboxamide cycloamino ureas |
| US8802868B2 (en) | 2010-03-25 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
| KR20190061096A (ko) | 2010-04-22 | 2019-06-04 | 버텍스 파마슈티칼스 인코포레이티드 | 시클로알킬카르복스아미도-인돌 화합물의 제조 방법 |
| US9630956B2 (en) | 2010-05-12 | 2017-04-25 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| EP2569284B1 (en) | 2010-05-12 | 2015-07-08 | Vertex Pharmaceuticals Incorporated | 2-aminopyridine derivatives useful as inhibitors of atr kinase |
| EP2568984A1 (en) | 2010-05-12 | 2013-03-20 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| US9334244B2 (en) | 2010-05-12 | 2016-05-10 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| WO2011143419A1 (en) | 2010-05-12 | 2011-11-17 | Vertex Pharmaceuticals Incorporated | Pyrazines useful as inhibitors of atr kinase |
| EP2569286B1 (en) | 2010-05-12 | 2014-08-20 | Vertex Pharmaceuticals Inc. | Compounds useful as inhibitors of atr kinase |
| JP2013529643A (ja) | 2010-06-23 | 2013-07-22 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ａｔｒキナーゼ阻害剤として有用なピロロピラジン誘導体 |
| CN103068805A (zh) * | 2010-07-23 | 2013-04-24 | 索尔维公司 | 1-取代-3-氟烷基-吡唑-4-羧酸酯的制备方法 |
| CN101921268B (zh) * | 2010-08-27 | 2016-08-03 | 中山大学肿瘤防治中心 | 5-噻唑酰胺类化合物及生物学应用 |
| JP2013249256A (ja) * | 2010-09-15 | 2013-12-12 | Astellas Pharma Inc | 脂肪性肝疾患治療薬 |
| CA2806121C (en) | 2010-09-21 | 2018-10-09 | Eisai R&D Management Co., Ltd. | Pharmaceutical composition |
| MX2013011450A (es) | 2011-04-05 | 2014-02-03 | Vertex Pharma | Compuestos de aminopirazina utiles como inhibidores de la cinasa ataxia telangiectasia mutada y rad3 relacionados (atr). |
| WO2012178124A1 (en) | 2011-06-22 | 2012-12-27 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| EP2723745A1 (en) | 2011-06-22 | 2014-04-30 | Vertex Pharmaceuticals Inc. | Compounds useful as inhibitors of atr kinase |
| JP2014517079A (ja) | 2011-06-22 | 2014-07-17 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ａｔｒキナーゼ阻害剤として有用な化合物 |
| BR112014000887A2 (pt) | 2011-07-15 | 2016-09-13 | Basf Se | método para o combate ou o controle das pragas de invertebrados, método para a proteção das culturas, vegetais, material de propagação dos vegetais e/ou crescimento de vegetais do ataque ou infestação por pragas de invertebrados, método para o tratamento, controle, prevenção e proteção dos animais contra a infestação e infecção por parasitas, compostos de tiazol de 3-piridila, composto intermediário, processo para a preparação dos compostos de fórmula i, utilização de um composto de fórmula i-4, composição agrícola ou veterinária e semente |
| TW201309706A (zh) | 2011-07-22 | 2013-03-01 | Actelion Pharmaceuticals Ltd | 作為ｐ２ｘ７受體拮抗劑之雜環醯胺衍生物 |
| AU2012315611A1 (en) | 2011-09-30 | 2014-04-17 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| CN103987709B (zh) | 2011-09-30 | 2016-09-28 | 沃泰克斯药物股份有限公司 | 用于制备可用作atr激酶抑制剂的化合物的方法 |
| US8765751B2 (en) | 2011-09-30 | 2014-07-01 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| MX392542B (es) | 2011-09-30 | 2025-03-24 | Vertex Pharma | Tratamiento del cancer de pancreas y del cancer de pulmon de celulas no pequeñas con inhibidores de atr. |
| WO2013049720A1 (en) | 2011-09-30 | 2013-04-04 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| US8841337B2 (en) | 2011-11-09 | 2014-09-23 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| US8846917B2 (en) | 2011-11-09 | 2014-09-30 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| US8841449B2 (en) | 2011-11-09 | 2014-09-23 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| WO2013071093A1 (en) | 2011-11-09 | 2013-05-16 | Vertex Pharmaceuticals Incorporated | Pyrazine compounds useful as inhibitors of atr kinase |
| US8846918B2 (en) | 2011-11-09 | 2014-09-30 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| CN104066721B (zh) * | 2011-11-30 | 2016-03-30 | 拜耳知识产权有限责任公司 | 杀真菌的n-二环烷基和n-三环烷基吡唑-4-（硫代）羧酰胺衍生物 |
| CN102603637A (zh) * | 2012-01-18 | 2012-07-25 | 中国药科大学 | 吡唑化合物及其作为rtk和pi3k双重抑制剂的用途 |
| AU2013210682B2 (en) | 2012-01-20 | 2017-05-25 | Idorsia Pharmaceuticals Ltd | Heterocyclic amide derivatives as P2X7 receptor antagonists |
| CN104582795B (zh) | 2012-04-05 | 2018-04-20 | 沃泰克斯药物股份有限公司 | 可用作atr激酶抑制剂的化合物及其组合疗法 |
| CN104640442A (zh) | 2012-06-14 | 2015-05-20 | 巴斯夫欧洲公司 | 使用取代3-吡啶基噻唑化合物和衍生物防除动物有害物的灭害方法 |
| EP2897953B8 (en) * | 2012-09-19 | 2019-06-26 | Cyclerion Therapeutics, Inc. | Sgc stimulators |
| US9802899B2 (en) | 2012-10-02 | 2017-10-31 | Bayer Cropscience Ag | Heterocyclic compounds as pesticides |
| WO2014055756A1 (en) | 2012-10-04 | 2014-04-10 | Vertex Pharmaceuticals Incorporated | Method for measuring atr inhibition mediated increases in dna damage |
| EP2909202A1 (en) | 2012-10-16 | 2015-08-26 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| US8871754B2 (en) | 2012-11-19 | 2014-10-28 | Irm Llc | Compounds and compositions for the treatment of parasitic diseases |
| HUE037600T2 (hu) | 2012-11-19 | 2018-09-28 | Novartis Ag | Vegyületek és készítmények paraziták által okozott fertõzések kezelésére |
| PL3486245T3 (pl) | 2012-12-07 | 2021-11-08 | Vertex Pharmaceuticals Incorporated | 2-amino-n-(piperydyn-1-ylo-pirydyn-3-ylo) pirazolo[1,5alfa]pirymidyno-3-karboksyamid jako inhibitor kinazy atr |
| EA029644B1 (ru) | 2012-12-12 | 2018-04-30 | Идорсиа Фармасьютиклз Лтд | Индолкарбоксамидные производные в качестве антагонистов p2xрецепторов |
| CA2891499C (en) | 2012-12-18 | 2021-07-06 | Actelion Pharmaceuticals Ltd | Indole carboxamide derivatives as p2x7 receptor antagonists |
| ES2616114T3 (es) | 2013-01-22 | 2017-06-09 | Actelion Pharmaceuticals Ltd. | Derivados de amida heterocíclica como antagonistas del receptor P2X7 |
| JP6282017B2 (ja) * | 2013-01-22 | 2018-02-21 | イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | Ｐ２ｘ７受容体アンタゴニストとしての複素環アミド誘導体 |
| WO2014143240A1 (en) | 2013-03-15 | 2014-09-18 | Vertex Pharmaceuticals Incorporated | Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase |
| DK3077397T3 (da) | 2013-12-06 | 2019-12-16 | Vertex Pharma | 2-amino-6-fluor-n-[5-fluor-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamidforbindelse anvendelig som atr-kinase-inhibitor, dens fremstilling, forskellige faste former og radiomarkerede derivater deraf |
| AR099895A1 (es) | 2014-04-02 | 2016-08-24 | Bayer Cropscience Ag | Compuestos heterocíclicos como agentes para combatir parásitos |
| US10206877B2 (en) | 2014-04-15 | 2019-02-19 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases |
| CA2950587C (en) | 2014-06-05 | 2022-06-28 | Vertex Pharmaceuticals Incorporated | Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, the preparation of said compound and different solid forms thereof |
| US11179394B2 (en) | 2014-06-17 | 2021-11-23 | Vertex Pharmaceuticals Incorporated | Method for treating cancer using a combination of Chk1 and ATR inhibitors |
| AR098108A1 (es) * | 2014-07-31 | 2016-05-04 | Dow Agrosciences Llc | Proceso para la preparación de 3-(3-cloro-1h-pirazol-1-il)piridina |
| EP3186229A4 (en) * | 2014-07-31 | 2018-01-10 | Dow AgroSciences LLC | Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine |
| US9029555B1 (en) * | 2014-07-31 | 2015-05-12 | Dow Agrosciences Llc | Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine |
| US9963462B2 (en) * | 2015-09-30 | 2018-05-08 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Sepiapterin reductase inhibitors |
| RU2768621C1 (ru) | 2015-09-30 | 2022-03-24 | Вертекс Фармасьютикалз Инкорпорейтед | Способ лечения рака с использованием комбинации повреждающих днк средств и ингибиторов atr |
| TW201722432A (zh) | 2015-11-02 | 2017-07-01 | Ｈ 朗德貝克公司 | Ｐ２ｘ受體之抑制劑 |
| CN106187910A (zh) * | 2016-07-07 | 2016-12-07 | 浙江大学 | 哒嗪类衍生物及其制备方法和用途 |
| EP3498269A1 (en) | 2017-12-12 | 2019-06-19 | Dompé farmaceutici S.p.A. | C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain |
| JP6995195B2 (ja) * | 2018-05-18 | 2022-02-04 | 富士フイルム株式会社 | ３－ジフルオロメチルピラゾール化合物の製造方法及び３－ジフルオロメチルピラゾール－４－カルボン酸化合物の製造方法、並びに、ピラゾリジン化合物 |
| TWI867088B (zh) * | 2019-11-06 | 2024-12-21 | 德商拜耳廠股份有限公司 | 經取代之雜環甲醯胺及其用途 |
| HRP20241695T1 (hr) | 2019-12-06 | 2025-02-14 | Vertex Pharmaceuticals Incorporated | Supstituirani tetrahidrofurani kao modulatori natrijevih kanala |
| KR20230035608A (ko) * | 2020-07-06 | 2023-03-14 | 프락시스 프리시젼 메디신즈, 인크. | Kcnt1 억제제 및 사용 방법 |
| KR20240031300A (ko) | 2021-06-04 | 2024-03-07 | 버텍스 파마슈티칼스 인코포레이티드 | 나트륨 채널 조절제로서의 n-(하이드록시알킬 (헤테로)아릴) 테트라하이드로푸란 카르복스아미드 |
| WO2024196698A2 (en) * | 2023-03-17 | 2024-09-26 | Curadh Mtr | Compounds and constructs useful for targeting fibroblast activation protein |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA962269A (en) * | 1971-05-05 | 1975-02-04 | Robert E. Grahame (Jr.) | Thiazoles, and their use as insecticides |
| US3852293A (en) * | 1972-06-21 | 1974-12-03 | Uniroyal Inc | 4-phenyl-2-(3-pyridyl)-thiazole carboxamides |
| KR970705560A (ko) * | 1995-08-02 | 1997-10-09 | 호아껭 우리아치 토렐로 | 항진균 활성을 갖는 신규한 카르복사미드(new carboxamides with antifungal activity) |
| US6323227B1 (en) * | 1996-01-02 | 2001-11-27 | Aventis Pharmaceuticals Products Inc. | Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| WO1998041519A1 (en) * | 1997-03-18 | 1998-09-24 | Smithkline Beecham Corporation | Novel cannabinoid receptor agonists |
| SE9704545D0 (sv) * | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
| SE9704544D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
| CN101481359A (zh) * | 1999-04-15 | 2009-07-15 | 布里斯托尔-迈尔斯斯奎布公司 | 环状蛋白酪氨酸激酶抑制剂 |
| US7125875B2 (en) * | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
| DE60023128T2 (de) * | 1999-05-12 | 2006-07-06 | Ortho-Mcneil Pharmaceutical, Inc. | Pyrazolcarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen |
| PE20011010A1 (es) * | 1999-12-02 | 2001-10-18 | Glaxo Group Ltd | Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano |
| GB0011095D0 (en) * | 2000-05-08 | 2000-06-28 | Black James Foundation | astrin and cholecystokinin receptor ligands (III) |
| WO2003037274A2 (en) * | 2001-11-01 | 2003-05-08 | Icagen, Inc. | Pyrazole-amides and-sulfonamides |
| WO2003037330A1 (en) * | 2001-11-02 | 2003-05-08 | Pfizer Products Inc. | Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors |
| PA8557501A1 (es) * | 2001-11-12 | 2003-06-30 | Pfizer Prod Inc | Benzamida, heteroarilamida y amidas inversas |
| WO2008011131A2 (en) | 2006-07-21 | 2008-01-24 | Takeda Pharmaceutical Company Limited | Amide compounds |
| CN1732164A (zh) * | 2002-10-30 | 2006-02-08 | 沃泰克斯药物股份有限公司 | 可用作rock及其他蛋白质激酶抑制剂的组合物 |
| AR043057A1 (es) * | 2002-10-30 | 2005-07-13 | Vertex Pharma | Compuestos derivados de piridintiazoles como inhibidores de la quinasa rock y otras proteinas quinasa |
| DK1567493T3 (da) | 2002-11-26 | 2009-06-08 | Pfizer Prod Inc | Phenyl-substituerede piperidin-forbindelser til anvendelse som PPAR-aktivatorer |
| EP1583742B1 (en) * | 2003-01-02 | 2009-12-02 | F. Hoffmann-La Roche Ag | Cb 1 receptour inverse agonists |
| US20040220170A1 (en) * | 2003-05-01 | 2004-11-04 | Atkinson Robert N. | Pyrazole-amides and sulfonamides as sodium channel modulators |
| MXPA05011922A (es) * | 2003-05-07 | 2006-02-17 | Pfizer Prod Inc | Ligandos del receptor de cannabinoides y sus usos. |
| BRPI0410349A (pt) * | 2003-05-12 | 2006-05-30 | Pfizer Prod Inc | inibidores de benzamida do receptor p2x7 |
| US7223780B2 (en) * | 2003-05-19 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Triazole-derivatives as blood clotting enzyme factor Xa inhibitors |
| EP1479679A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Triazole-derivatives as factor Xa inhibitors |
| HRP20110757T1 (hr) * | 2003-06-26 | 2011-11-30 | Novartis Ag | Inhibitori kinaze p38 bazirani na 5-članom heterociklu |
| SE0302192D0 (sv) * | 2003-08-08 | 2003-08-08 | Astrazeneca Ab | Novel compounds |
| CA2540978A1 (en) * | 2003-10-08 | 2005-04-21 | Vertex Pharmaceuticals Incorporated | Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| WO2005037199A2 (en) * | 2003-10-10 | 2005-04-28 | Bristol-Myers Squibb Company | Pyrazole derivatives as cannabinoid receptor modulators |
| KR20060121185A (ko) | 2003-11-14 | 2006-11-28 | 버텍스 파마슈티칼스 인코포레이티드 | Ａｔｐ-결합 카세트 전달체의 조절자로서 유용한 티아졸 및옥사졸 |
| WO2005061462A2 (en) | 2003-12-19 | 2005-07-07 | Neurogen Corporation | Diaryl pyrazole derivatives and their use as neurokinin-3 receptor modulators |
| MXPA06008606A (es) * | 2004-01-30 | 2007-04-13 | Vertex Pharma | Moduladores de transportadores con casete de union a atp. |
| CA2561977A1 (en) * | 2004-03-30 | 2005-10-13 | Chiron Corporation | Substituted thiophene derivatives as anti-cancer agents |
| EP1745019A1 (en) * | 2004-05-06 | 2007-01-24 | Pfizer Inc. | Novel compounds of proline and morpholine derivatives |
| DE102004051277A1 (de) * | 2004-10-21 | 2006-04-27 | Merck Patent Gmbh | Heterocyclische Carbonylverbindungen |
| US7728009B1 (en) * | 2005-02-18 | 2010-06-01 | Neurogen Corporation | Thiazole amides, imidazole amides and related analogues |
| EP1917262B1 (en) * | 2005-08-15 | 2011-12-14 | F. Hoffmann-La Roche AG | Piperidine and piperazine derivatives as p2x3 antagonists |
| CN101304981A (zh) | 2005-11-07 | 2008-11-12 | 艾博特公司 | P2x7受体拮抗剂及使用方法 |
| EP1963275A2 (en) | 2005-11-09 | 2008-09-03 | Abbott Laboratories | P2x7 receptor antagonists and uses thereof |
| WO2007087283A2 (en) | 2006-01-23 | 2007-08-02 | Vertex Pharmaceuticals Incorporated | Thiophene-carboxamides useful as inhibitors of protein kinases |
| PL2029572T3 (pl) * | 2006-06-05 | 2011-05-31 | Novartis Ag | Związki organiczne |
| AU2007308154A1 (en) * | 2006-10-10 | 2008-04-17 | Amgen Inc. | N-aryl pyrazole compounds for use against diabetes |
| EP2121621B1 (en) | 2006-12-08 | 2014-05-07 | Exelixis Patent Company LLC | Lxr and fxr modulators |
| CL2008000836A1 (es) | 2007-03-26 | 2008-11-07 | Actelion Pharmaceuticals Ltd | Compuestos derivados de tiazolidina, antagonistas del receptor de orexina; composicion farmaceutica que los comprende; y su uso en el tratamiento de neurosis emocional, depresion grave, trastornos psicoticos, alzheimer, parkinson, dolor, entre otras. |
| EP2155685B1 (en) | 2007-05-10 | 2011-03-16 | Glaxo Group Limited | Pyrazole derivatives as p2x7 modulators |
-
2008
- 2008-07-21 PL PL08796352T patent/PL2178865T3/pl unknown
- 2008-07-21 JP JP2010517200A patent/JP2010533736A/ja active Pending
- 2008-07-21 EP EP08796352.6A patent/EP2178865B1/en active Active
- 2008-07-21 UA UAA200913338A patent/UA105758C2/uk unknown
- 2008-07-21 HU HUE08796352A patent/HUE026446T2/en unknown
- 2008-07-21 WO PCT/US2008/070613 patent/WO2009012482A2/en not_active Ceased
- 2008-07-21 DK DK08796352.6T patent/DK2178865T3/en active
- 2008-07-21 EA EA200971084A patent/EA017250B1/ru not_active IP Right Cessation
- 2008-07-21 CA CA2691507A patent/CA2691507C/en not_active Expired - Fee Related
- 2008-07-21 ES ES08796352.6T patent/ES2551095T3/es active Active
- 2008-07-21 SG SG2012095287A patent/SG187396A1/en unknown
- 2008-07-21 KR KR1020157026989A patent/KR20150118197A/ko not_active Ceased
- 2008-07-21 BR BRPI0813426-0A2A patent/BRPI0813426A2/pt not_active Application Discontinuation
- 2008-07-21 HR HRP20151052TT patent/HRP20151052T1/hr unknown
- 2008-07-21 PT PT87963526T patent/PT2178865E/pt unknown
- 2008-07-21 KR KR1020097026691A patent/KR101593237B1/ko not_active Expired - Fee Related
- 2008-07-21 NZ NZ582057A patent/NZ582057A/en not_active IP Right Cessation
- 2008-07-21 AU AU2008275891A patent/AU2008275891B2/en not_active Ceased
- 2008-07-21 US US12/669,308 patent/US20100292236A1/en not_active Abandoned
- 2008-07-21 SI SI200831516T patent/SI2178865T1/sl unknown
- 2008-07-21 CN CN201510081896.5A patent/CN104844578B/zh not_active Expired - Fee Related
- 2008-07-21 RS RS20150681A patent/RS54303B1/sr unknown
- 2008-07-21 MX MX2009014159A patent/MX2009014159A/es active IP Right Grant
- 2008-07-21 CN CN200880021346.2A patent/CN101711245B/zh not_active Expired - Fee Related
- 2008-07-21 MY MYPI20095491A patent/MY154668A/en unknown
-
2009
- 2009-11-30 ZA ZA2009/08447A patent/ZA200908447B/en unknown
- 2009-12-03 IL IL202499A patent/IL202499A/en active IP Right Grant
- 2009-12-22 CO CO09146583A patent/CO6251318A2/es active IP Right Grant
-
2013
- 2013-11-25 JP JP2013243253A patent/JP5813734B2/ja not_active Expired - Fee Related
-
2014
- 2014-07-23 PH PH12014501677A patent/PH12014501677B1/en unknown
- 2014-09-09 US US14/480,979 patent/US9133204B2/en not_active Expired - Fee Related
-
2015
- 2015-10-22 CY CY20151100944T patent/CY1116809T1/el unknown
-
2016
- 2016-02-18 HK HK16101727.0A patent/HK1213879A1/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010533736A5 (enExample) | ||
| EP1578745B1 (en) | BENZOFURAN DERIVATivES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES THEREOF | |
| CA2915561C (en) | Novel substituted bicyclic compounds as bromodomain inhibitors | |
| JP5813734B2 (ja) | ５員複素環アミドおよび関連化合物 | |
| AU2016249273B2 (en) | Bromodomain inhibitor | |
| US9604980B2 (en) | Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors | |
| TWI415845B (zh) | 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物 | |
| AU2006212761B2 (en) | Combination therapy | |
| RU2559895C2 (ru) | Азотосодержащие производные гетероарилов | |
| JP2010535816A5 (enExample) | ||
| CN101184395A (zh) | 包含二芳基胺的化合物和组合物及其作为类固醇激素核受体调节剂的用途 | |
| WO2010072166A1 (zh) | 二氢化茚酰胺化合物制备方法、包含其的药物组合物、及其作为蛋白激酶抑制剂的应用 | |
| JP2010510987A5 (enExample) | ||
| EP2753327A2 (en) | Amido compounds as ror-gamma-tmodulators and uses thereof | |
| JP2007517887A5 (enExample) | ||
| UA120571C2 (uk) | Алостеричні модулятори нікотинових ацетилхолінових рецепторів | |
| JP2010530427A (ja) | 多環式グアニン誘導体およびその使用方法 | |
| CN103402995B (zh) | 吲哚、吲唑衍生物或其盐 | |
| WO2014180165A1 (zh) | 苯并异噻唑类化合物及在制备抗精神分裂症药物中的应用 | |
| WO2014086102A1 (zh) | 作为酪氨酸激酶抑制剂的吲哚满酮衍生物 | |
| CN102083831A (zh) | 用作aurora激酶抑制剂的萘啶酮 | |
| JPS6230780A (ja) | １，７−ナフチリジン誘導体及びこれを含有する薬剤 | |
| CN101827595B (zh) | 作为神经肽y2受体调节剂的取代的哌嗪和哌啶类 | |
| BR112020014584A2 (pt) | inibição do canal iônico do receptor de potencial transitório a1 | |
| JP2009511547A (ja) | 不安及び関連疾患の治療のためのイミダゾール誘導体 |